Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

Trial Profile

Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs Malaria vaccine live unattenuated-Sanaria (Primary) ; Chloroquine
  • Indications Malaria
  • Focus Adverse reactions
  • Sponsors Sanaria
  • Most Recent Events

    • 12 Mar 2015 New source identified and integrated (European Clinical Trials Database; EudraCT2012-000322-21)
    • 14 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Jan 2014 According to ClinicalTrials.gov record trial status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top